{"status": "Ok", "redirect_url": "https://www.businesswire.com/news/home/20260826599082/en/Robbins-LLP-Urges-Investors-of-ARS-Pharmaceuticals-Inc.-to-Contact-the-Firm-for-Information-About-the-SPRY-Securities-Class-Action-Lawsuit", "message": "News view counter 903821 successfully enlarged"}